Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03852498 Completed - Clinical trials for Cerebral Adrenoleukodystrophy (CALD)

A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Start date: January 24, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Lenti-D Drug Product (also known as elivaldogene autotemcel or Skysona, hereafter referred to as eli-cel) after myeloablative conditioning with busulfan and fludarabine in participants with CALD. A participant's blood stem cells will be collected and modified (transduced) using the Lenti-D lentiviral vector encoding human adrenoleukodystrophy protein. After modification (transduction) with the Lenti-D lentiviral vector, the cells will be transplanted back into the participant following myeloablative conditioning. Enrollment and treatment in Study ALD-104 have been completed and further enrollment in this study is not expected, although participants follow-up remains ongoing in the long-term follow-up Study LTF-304 (NCT02698579).

NCT ID: NCT03852485 Completed - Clinical trials for Normal Eyes and Eyes With Ocular Pathologies

Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate

Start date: January 29, 2019
Phase:
Study type: Observational

Comparison of OCT and OCTA-based Ocular Measurements to those of Predicate

NCT ID: NCT03851705 Completed - Clinical trials for Homozygous Familial Hypercholesterolemia

A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

ORION-5
Start date: February 6, 2019
Phase: Phase 3
Study type: Interventional

This study was a Phase III,A two-part (double-blind placebo-controlled/open-label) multicenter study to evaluate safety, tolerability, and efficacy of inclisiran in subjects with homozygous familial hypercholesterolemia (HoFH).

NCT ID: NCT03851367 Completed - Clinical trials for Juvenile Osteochondrosis of Spine

Sling Suspension Versus Gym Balls in the Treatment of Juvenile Spinal Osteochondrosis

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This study compares effect of swiss ball exercises with sling suspension exercises in the treatment of juvenile osteochondrosis in adolescent-girls

NCT ID: NCT03851055 Completed - Clinical trials for Beta-thalassemia Major Complicated With Diabetes

Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus

Start date: August 1, 2017
Phase: Phase 3
Study type: Interventional

Beta-thalassemia represents a group of recessive inherited hemoglobin disorders characterized by reduced synthesis of β-globin chain. The homozygous state (β-thalassemia major) "TM" results in severe anemia, which needs regular blood transfusion . The life expectancy in patients with TM has increased due to therapeutically management, such as frequent transfusion, desferal administration and bone marrow transplantation. Diabetes is clinically characterized by hyperglycemia due to either low circulating concentrations of, or decreased sensitivity to, insulin. Patients with TM typically exhibit β-cell or insulin insufficiency, and may develop diabetes due to toxic levels of iron in their pancreas, one of the strongest predictors of β-cell destruction. By contrast, hyperinsulinemia, secondary to insulin resistance, with normal glucose tolerance has also been observed. The pathogenic mechanisms leading from siderosis to diabetes are poorly understood.

NCT ID: NCT03850886 Completed - Clinical trials for Non Alcoholic Fatty Liver Disease

Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients

Start date: January 15, 2019
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of Niacinamide supplementation on clinical outcome of fatty liver patients having type II DM through measurement of the following before and after Niacinamide administration: Liver enzymes, Lipid profie, HOMA-IR, Oxidative stress markers and endothelial dysfunction marker. Fibroscan with CAP will be done at baseline and at the end of the trial. Also, Evaluation of quality of life of patients before and after Niacinamide administration using Chronic Liver Disease questionnaire.

NCT ID: NCT03850743 Completed - Clinical trials for Post Surgical Pain and Sleep Impairment

Biomarker Signatures of the Sleep-pain Enigma

Start date: February 2, 2019
Phase:
Study type: Observational

This is an observational, prospective study that will leverage existing Standard of Care (SOC) patient reported outcomes (PRO) and Electronic Medical Record (EMR) data and collect additional Pain Rating Scale (PRS) data and blood samples from patients who consent to be in the study. Active duty service members and DEERS eligible patients who are injured and/or will undergo elective orthopaedic surgery are the target population.

NCT ID: NCT03850249 Completed - Clinical trials for Posttraumatic Radiocarpal Osteoarthritis

Radioscapholunate Fusions After Wrist Trauma

Radioscapho
Start date: January 1, 2018
Phase:
Study type: Observational

The investigators conduced a clinical trial to evaluate the clinical and radiographic results after radioscapholunate fusion in case of posttraumatic radiocarpal osteoarthritis. Because of poor clinical result, many authors upgrade the procedure including excision of the distal pole of the scaphoid and later excision of the entire triquetrum. Only one study compared the three procedures in 17 patients. The investigators performed the same comparison in 85 patients with a mean follow up of 9,1 years (1-23)

NCT ID: NCT03850158 Completed - Endometriosis Clinical Trials

Diagnostic Value of ICG in Endometriosis

Start date: January 2017
Phase: Early Phase 1
Study type: Interventional

This study evaluates the diagnostic value of the addition of indocyanine green and near infrared fluorescence imaging during laparoscopy in patients with suspected endometriosis.

NCT ID: NCT03849911 Completed - Clinical trials for Neurological Prognosis Cardiac Arrest

EEG and SEP Evaluation for Good and Poor Neurological Prognosis After Cardiac Arrest

ProNeCA
Start date: June 1, 2016
Phase:
Study type: Observational

Hypoxic-Ischemic-encephalopathy (HIE) is a severe and frequent neurological complication of successful cardiopulmonary-resuscitation after cardiac arrest (CA). Prognosticating neurological outcomes in patients with HIE is challenging and recent guidelines suggest a multimodal approach. Only few studies have analyzed the prognostic power of the association between instrumental tests and, in addition, most of them were monocentric, retrospective and evaluating only poor outcome.